Skip to main content

AmchoPlast

AmchoPlast is a cutting-edge, sterile, minimally manipulated, dehydrated allograft designed to support homologous use in clinical applications. It is meticulously derived from human placental membranes, specifically the amnion, intermediate layer, and chorion, obtained from healthy, consenting donors. The allograft incorporates a basement membrane and a stromal matrix collagen layer, providing structural integrity and biological compatibility for therapeutic purposes. AmchoPlast provides an optimal scaffold for tissue regeneration and repair, promoting wound healing and cellular integration. Its biocompatible properties make it ideal for use in managing acute and chronic wounds, surgical procedures, and other tissue repair scenarios.

Cellution Biologics

Cellution Biologics is a regenerative medicine company specializing in advanced human tissue–based allografts for surgical, wound care, and specialty clinical applications. With a focus on scientific rigor, innovation, and quality, Cellution Biologics Inc. partners with clinicians to deliver solutions that enhance healing while supporting operational excellence across diverse care settings.

Toll free:(888) 575-7357 Website: https://www.cellutionbiologics.com/
Benefits

• Improves Wound Closure in Chronic Diabetic Foot Ulcers: 71% healed vs 23% with standard care alone.1
• Biologic Scaffold Supporting Natural Healing: retains key growth factors to support tissue repair and epithelialization.
• Broad Wound Applicability: Chronic ulcers (diabetic, pressure, venous), Surgical and reconstructive wounds, Traumatic wounds (burns, abrasions, lacerations)
• Ambient Storage & Long Shelf-Life
• Easy to Use: ready-to-apply at point of care
• Compatible With Adjunct Therapies: Can be used alongside standard wound care protocols including NPWT and hyperbaric oxygen therapy as part of comprehensive treatment plans.

Reference

1. Hall HJ, Keenan A, Massey K, D'Costa WF, Moyer P. Bridging the Wound Gap: Interim Results From Randomized Trials Evaluating Dehydrated Human Amnion-Intermediate Layer-Chorion Membrane for the Treatment of Non-healing Diabetic Foot Ulcers. Cureus. 2025 Nov 26;17(11):e97875. doi: 10.7759/cureus.97875. PMID: 41458871; PMCID: PMC12743229.

Indications

AmchoPlast is restricted to homologous use. It acts as a barrier and provide a protective coverage from the surrounding environment for acute and chronic wounds such as partial and full thickness wounds, pressure sores/ ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/ undermined wounds, surgical wounds (eg, donor site/grafts, post-laser surgery, post-Mohs surgery, podiatric wounds, wound dehiscence), trauma wounds (eg, abrasions, lacerations, partial thickness burns, skin tears), and draining wounds.

Contraindications

AmchoPlast should not be used with known hypersensitivity to ofloxacin, vancomycin, and amphotericin B. It should not be used on (1) areas with active or latent infection and/or (2) a patient with a disorder that would create an unacceptable risk of postoperative complications.

Warnings and Precautions

1. Do not re-sterilize, keep away from sunlight, do not use if package is damaged and consult instructions for use, Keep dry, keep out of reach of children. Do not re-use. Contains biological material of human origin.
2. Caution should be used when treating patients with a known sensitivity to ofloxacin, vancomycin, and amphotericin antibiotics. Expert opinion is required before use on babies and pregnant women.
3. The graft is intended for single-patient use only.
4. Strict donor screening and laboratory testing, along with dedicated processing and sterilization methods are employed to reduce the risk of any disease transmission. However, as with all biological implants, an absolute guarantee of tissue safety is not possible. As with any allograft, complications at the graft site may occur post operatively that are not readily apparent. These include, but are not limited to the transmission of communicable diseases, including those of unknown etiology, transmission of infectious agents such as viruses, bacteria and fungi, immune rejection of, or allergic reaction to, implanted HCT/Ps.
5. Discard all damaged, mishandled or potentially contaminated tissue.
6. This product has not been tested in combination with other products.
7. AmchoPlast shall not be ordered, distributed or dispensed for veterinary use.

Adverse Effects/Reactions

As with any procedure the possibility of infection exists. Proprietary processing and validated sterilization methods are employed to eliminate potential deleterious components of the allograft. However, with biological implants, the possibility of rejection still exists. Complaints or adverse events, including the suspected transmission of diseases attributable to this allograft, should be reported immediately.
Please contact your local sales representative, authorized distributor, or at
customerservice@cellutionbiologics.com for information on returns. All products being returned must be in original unopened container, packaging, original label and in resalable condition.

Storage Requirements

Store in a clean and dry environment at ambient temperature. DO NOT FREEZE. The distributor, intermediary and/or end-user clinician or facility is responsible for storing product under appropriate conditions prior to further distribution or implantation.

Inactive Ingredients

AmchoPlast retains the inherent collagens, growth factors, and proteins of the native tissue.

How Supplied/Sizing
ACM0014, 8906158200694, 14mm disc; ACM0018, 8906158200700, 18mm disc; ACM0202, 8906158200717, 2cm x 2cm; ACM0203 8906158200724 2cm x 3cm; ACM0204, 8906158200731, 2cm x 4cm; ACM0303, 8906158200304, 3cm x 3cm; ACM0305, 8906158200656, 3cm x 5cm; ACM0404, 890
HCPCS Code
Product features
check_circle Assigned HCPCS code
check_circle Minimally manipulated
cancel Cryopreserved
cancel Dehydrated
cancel Desiccated
cancel Flowable
cancel Micronized
check_circle Sheet form
cancel Requires refrigeration
cancel Shelf life greater than 2 years
cancel Shelf life limited
check_circle Indicated for acute wounds
check_circle Indicated for chronic wounds
check_circle Indicated for diabetic ulcers
check_circle Indicated for pressure ulcers
check_circle Indicated for surgical wounds
cancel Indicated for third-degree burns
check_circle Indicated for venous ulcers
cancel Contact manufacturer for usage guidelines
Other features
check_circle Educational Material Available
check_circle Free Samples/Trials Available
check_circle Published Clinical Article Available
Recommended Use

Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Diabetic Foot
Hypertrophic Scars/Keloids
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Pressure Ulcers
Sloughy Wounds
Surgical Wounds
Venous Ulcers

Mode of Use/Application

Step 1: Remove the allograft from the outer packaging.
Step 2: Inspect the pouch packaging. DO NOT USE if the packaging is damaged, if elements are
missing or appear to have been tampered with, if the labeling is illegible, or if the expiration date occurs in the past.
Step 3: Utilizing aseptic technique, peel open the outer pouch and place the inner pouch to the sterile field.
Step 4: Wait to open the inner pouch until ready to place the graft. Locate the tear notch on the pouch, and tear open.
Step 5: Using sterile non-toothed forceps, remove the graft and place it directly at the surgical or wound site. Allograft can be trimmed with a sterile sharp scissor in its dry state if there is a requirement.
Step 6: Apply AmchoPlast on the wound gently with sterile forceps and spread the membrane to maximize the contact with the wound surface. If needed, prior to application, the membrane can be hydrated with sterile saline solution. When necessary secure using the physician’s choice of fixation. Note: Allografts are human tissue products and appearance may vary between donors. Variations in color, opacity, and thickness are normal due to the nature of human tissue.

Removal & Change Frequency

AmchoPlast is typically applied to a prepared wound bed and left undisturbed to allow incorporation, with the graft itself not routinely removed; instead, it integrates or resorbs over time. In common clinical practice, the cover dressing is assessed and changed at follow-up visits, often around 7 days, with subsequent evaluations occurring weekly or as clinically indicated. Reapplication, if needed, is commonly considered on a weekly to biweekly basis depending on wound progress, exudate level, and patient factors. There is no fixed removal or change interval, and the overall treatment plan, dressing changes, and reapplication frequency are determined at the discretion of the healthcare provider based on individual wound characteristics and response to therapy.

No posters match your selected filters. Remove some filtres, or reset them and start again.

Have a product to submit?

Be included in the most comprehensive wound care products directory
and online database.
Learn More